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The 40 years of Michel Daudon’s working life in the ﬁeld of urolithiasis are difﬁcult to sum
up in a few lines. His knowledge, expertise and publications in the ﬁelds of biology,
chemistry, nephrology, and eventually urology have contributed to make him a national
and international recognized researcher in the understanding of the complex mechanisms
of urolithogenesis. His great collaboration with the community of nephrologists, kidney
physiologists, biologists, and urologists, seniors or in training, has widely contributed to
improve modern and complete treatments of urolithiasis, which is at the origin of
complicated urinary stones causing severe consequences on renal function and true public
health problems. His hard working, his willingness, and the clarity of his presentations
contributed to make him a national and international recognized lecturer in France and
North Africa, where he created a network connecting laboratories with clinicians. Always
looking forward in his scientiﬁc ﬁeld, he has established links with approved research
teams, making them interested in working on urolithiasis, even though research on uro-
lithiasis disease seems to be less important than research on cancer.
© 2014 Académie des sciences. Published by Elsevier Masson SAS. This is an open access
article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).r é s u m é
La vie de travail de Michel Daudon ne peut se resumer en quelques lignes. Ses
competences en clinique, en biologie et en biochimie ont fait de lui un acteur reconnu sur
le plan national et international dans la comprehension des mecanismes de la lithogenese
urinaire, source de calculs souvent complexes aux consequences parfois graves. Il a
largement contribue a la prise en charge moderne et complete de la lithiase urinaire, en
permettant aux nephrologues cliniciens et physiologistes, aux biologistes, mais aussi aux
urologues seniors et/ou en formation, de mieux cerner la complexite des calculs renaux et
leurs consequences sur la fonction renale ayant un impact en sante publique. Son travail
incessant, sa disponibilite et la clarte de ses exposes ont contribue a le faire reconnaître
comme un enseignant recherche par la communaute urologique aussi bien en France que
dans les pays etrangers, notamment en Afrique du Nord, en creant des reseaux de
collaboration entre laboratoires et cliniciens. Toujours en eveil scientiﬁque, il a etabli des
liens avec des unites labellisees de recherche de haut niveau. Il a su les interesser).
005 Paris, France.
ed by Elsevier Masson SAS. This is an open access article under the CC BY-NC-ND license (http://
B. Dore, P. Meria / C. R. Chimie 19 (2016) 1389e13941390chercheurs a la lithiase urinaire, dont la genese est au moins aussi complexe que la can-
cerogenese, mais peut-e^tre trop souvent consideree comme secondaire, bien qu’ayant des
impacts de sante publique tout aussi importants, justiﬁant l’implication de ces structures
de recherche.
© 2014 Académie des sciences. Published by Elsevier Masson SAS. This is an open access
article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Almost 250 referenced publications by Michel Daudon
testify to the importance of his work. A survey of his 40
working years as a biologist specialized in the ﬁeld of
urolithiasis appears to be truly justiﬁed. But the risk was to
be reductive, since his collaborative work with his research
colleagues, biologists, clinicians and physicians, was
intensive.
His knowledge in the ﬁelds of biology, biochemistry and
physiology applied tomedicine quickly attracted specialists
involved in the treatment of various diseases, characterized
by crystallization phenomena, such as nephrologists,
rheumatologists, cardiologists, and obviously urologists,
whose main area of interest was urolithiasis.
The ﬁrst publication from Michel Daudon in 1978
focused on the spectrophotometric analysis of gallbladder
stones [1] and did not foresee its forthcoming intellectual
“crystallization” on urinary lithogenesis and lithogenic
diseases. Two meetings directed Michel Daudon’s re-
searches on urolithiasis. The ﬁrst one led him to work with
R.-J. Reveillaud at the laboratory of biochemistry (CRISTAL
Laboratory) in Saint-Cloud hospital, which was dedicated
to urinary stone analysis. The second one allowed him to
collaborate with P. Jungers, professor of nephrology at
Necker hospital, inwhich he entered the laboratory headed
by M. Lacour, after Reveillaud’s death. Such meetings
initiated his passion for research and led him to seek to
understand the complex mechanisms of lithogenesis,
particularly those of urinary stones, and the deepest
mechanisms of nephron functioning [2]. Their collaborative
studies on the epidemiology of urolithiasis and the risk
factors of lithogenesis contributed to the analysis and un-
derstanding of various factors increasing the risk of recur-
rence of urolithiasis and their clinical and economic
consequences on public health [3,4].
At the beginning of the 1980s, R.J. Reveillaud and
M. Daudon developed the bases of a clinical-biological
confrontation between the composition and the crystal-
line architecture of urinary stones, most often very het-
erogeneous, and their association with the various and
complex mechanisms involved in their formation [5].
In collaboration with P. Jungers, they studied the factors
of recurrence of oxalate stones in patients treated with
piridoxylate [6].
Quickly, the members of the urolithiasis committee of
the French urological association (CLAFU) understood the
importance of Daudon’s work in the ﬁeld of stone analysis
at the time when new techniques such as extracorporeal
lithotripsy (ESWL), percutaneous nephrolithotomy (PCNL)
and retrograde ureteroscopy were emerging.
In this article, we aim at describing this collaboration.2. Collaborations with urologists
2.1. Clinical research
Clinical research was Daudon’s main topic.
2.1.1. The CLAFU
Hewas involved in clinical research right from the start of
the CLAFU in 1994 and continues to help the urologists in
their research themes and in the setup of recommendations
and clinical guidelines [7]. The objectives of the committee
remains to make the urologists sensitive to the systematic
realization of efﬁcient metabolic patient’s assessment,
coupled with the physical analysis of the stones expelled
after the ﬁrst renal colic and that of the fragments extracted
by the modern techniques of treatment. Many other themes
were addressed by the committee, due to M. Daudon’s dili-
gence and that of P. Jungers, M. Normand and J.-P. Haymann
as contributing nephrologists. So, he brought his experience
in various ﬁelds, such as ESWL, inwhich from 1989 he could
foresee the importance of the frequency of the shock waves
on thequalityof fragmentationaswell as thatof thenature of
the stones [8,9].Hehelped theurologists to takean interest in
the correlations between stone composition and lithogenic
diseases [10], and between lithogenesis and different aspects
ofmetabolism. He focused on variousmechanisms related to
phosphate, calcium oxalate [11], uric acid, metabolic syn-
drome, diabetes, pregnancy and infection [12e16].
But one of the most important contributions of
M. Daudon for the urologists was to make them aware of
the importance of stones collection after removal, intended
for physical analysis that replaced the obsolete chemical
analysis. Stone analysis with infrared spectrophotometry
(SPIR) corrected many diagnostic errors previously related
to the discriminative inadequacy of chemical analysis. The
highlighting of the type Ic calcium oxalate monohydrated
stone allowed early recognition and treatment of primary
hyperoxaluria, a serious lithogenic disease affecting chil-
dren and adults [17e19], in which crystalluria is a simple
and reliable tool [20]. Likewise, the diffusion of the SPIR
diagnosis of 2.8-dihydroxyadenin stones, related to
adenine phosphoribosyl transferase deﬁciency, allowed
many biologists taught by M. Daudon to perform an early
diagnosis of such a disease [21]. Its genetic identiﬁcation
should facilitate preventive measures and adapted treat-
ment (allopurinol) of this serious and recurrent disease
affecting adults and children and requiring sometimes
kidney transplantation [22e29].
2.1.2. Cystinuria
Daudon proposed and coordinated with the CLAFU a
national survey on cystinuria. This collaborative work,
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more than 600 patients in an exhaustive study, whose re-
sults are in press [30]. This retrospective study, focusing on
a rare disease, whose treatment remains difﬁcult, is one of
the most important ones in the literature. It supplements
numerous collaborative publications on clinical and
fundamental research that demonstrated the pathogen
mutation of a part of the Slc3a1 in an animal model, similar
to the human case [31e35].
2.1.3. Endoprosthesis encrustations
The collaborative work with urologists allowed Daudon
to study a diversity of encrustations in various biomaterials
constituting endoprostheses, either in non-lithiasic pa-
tients with bladder indwelling catheters or in lithiasic pa-
tients with “double-J” stents after stone treatment [36]. He
demonstrated that hydrogel-coated stents displayed faster
encrustation than others, requiring special surveillance and
frequent replacement [36e40]. Other researches were
performedwith cardiologists and vascular surgeons on bio-
prosthesis and aortic valves [41,42].2.1.4. Prevention of stone recurrence
Prevention of stone recurrence is a common objective of
urologists and nephrologists. Daudon always focused his
work on the role of the inhibitors and promoters of litho-
genesis. [43].
Three peculiar aspects can be reported:
 drinking waters are one of the most important pre-
ventive tools against stone recurrence, by the means
of the dissolution of crystals. Likewise, Daudon
collaborated with urologists to evaluate the inﬂuence
of different sorts of water and that of diuresis on
stone recurrence [44,45]. Nevertheless, this subject
remains controversial;
 Randall’s plaque currently displays a resurgence of
interest as a cause of stone recurrence. Its role as a
factor of nucleation of calcium carbonate amorphous
phosphate (PACC) and calcium phosphate was
addressed in numerous collaborative studies associ-
ating physicians, nephrologists and urologists under
Daudon’s coordination [46e50];
 urolithiasis and infection have a strong and complex
relation, which was widely studied by Daudon. He
collaborated with physicians and urologists to assess
infection stones due to urea splitting microorgan-
isms, responsible for phosphate ammoniac magne-
sium (struvite) and carbapatite stones. Using
spectrometry and neutronic diffraction, Daudon
demonstrated that only carbapatite displayed bacte-
rial imprints, since its crystals were smaller than
those of struvite [51].
Urolithiasis in VIH-infected patients receiving antiviral
agents (indinavir, ritonavir, atazanavir, darunavir, efavirenz,
foscarnet) was an important theme of research for Daudon
[52e54]. This work joined other researches on the relation
between urolithiasis and various drugs (ﬂumequin, amox-
icillin, ﬂuoroquinolones, oxolinic acid, piridoxilate) [55,56].2.1.5. Correlation between CT scan and stone analysis
The results of stone treatments, particularly ESWL, are
correlated with stone composition. Many works have been
done by urologists and radiologists, in association with
Daudon, who studied the composition of stone fragments
and compared pretreatment stone density (HU) with the
main component highlighted by SPIR analysis [57e59]. The
comparison of stone density measurements obtained with
various CT scan devices, however, did not allow the pre-
diction of various sorts of urinary stones identiﬁed by SPIR
analysis [60].
2.1.6. The French conference on urology
The collaboration between Daudon and the urologists
was also materialized by an important contribution to the
annual report of the French conference on urology in 2007,
in which Daudon addressed various themes, such as
epidemiology, lithogenesis, and its relation with the
metabolic syndrome [61e63].2.2. Teaching
Daudon contributed to spread the results of his clinical
and fundamental researches toward nephrologists, bi-
ologists and urologists, with whom he continues to
collaborate.
2.2.1. Teaching at the French College of Urology (enseignement
du college d’urologie [ECU])
Daudon is an active member of the different meetings
organized by the French College of Urology (College fran-
çais des urologues [CFU]), intended for young urologists in
training, under the responsibility of the French Association
of Urology (AFU). Likewise, he taught the trainees in the
ﬁelds of lithogenesis, epidemiology, and stone classiﬁcation
based on SPIR analysis, correlations between stone
composition and lithogenic diseases [64].
2.2.2. Workshops on urology (SUC)
Daudon was also involved in the medical continuing ed-
ucation intended for certiﬁed urologists. During the work-
shops (seminaire d’urologie continue [SUC]), he instructed
them on the recent advances in stone analysis by the means
of SPIR instead of chemical analysis, and contributed to a
better management of urolithiasis. He focused on the abso-
luteneed for stone collectionafter treatment for SPIRanalysis
[10] and on the importance for urologists:
 of the knowledge of the guidelines about metabolic
evaluation, recommended from the moment of the
ﬁrst clinical manifestation of urolithiasis, with the
aim of reducing the recurrence risk [7];
 of the collection of stone fragments for SPIR analysis
[65];
 of PCNL, which could be performed bilaterally and
safely during the same procedure under certain
conditions [66];
 of giving special consideration to VIH-infected pa-
tients due to the risk of upper urinary tract obstruc-
tion by drug-induced stones [67];
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the prostate during transuretral operations [68].2.2.3. The university diploma on urolithiasis
This diploma was created 15 years ago by Daudon and
remains attractive. It favors meetings between biologists,
nephrologists and urologists from Europe and North Africa.
All aspects of urolithiasis are covered during workshops in
which numerous exchanges and brainstorming meetings
are included. Young urologists are more and more
frequently present and this aspect testiﬁes to their
increasing interest in lithogenesis and consequently to the
exhaustive insight into urolithiasis they have got, allowing
a better management of the disease, including recurrence
prevention.
2.2.4. Clinical and biological confrontations on urolithiasis at
Necker hospital
The increasing links between urologists, nephrologists,
and biologists led to create such annual meetings 20 years
ago, which were intended for a better understanding of
urolithiasis and to favor exchanges on lithogenesis, pre-
ventive, and therapeutic measures. This collaborative
work was extended to the radiologists and the physicians
involved in fundamental research, such as D. Bazin.
Consequently, young urologists could develop master
research projects such as microscopic studies of stones by
means of synchrotrons [69], electronic microscopic
studies of Randall’s plaques and the role of heavy elements
such as zinc and strontium in calcic lithogenesis and se-
lenium in cystine lithogenesis [70].
2.2.5. Contribution to educational materials in urology
Daudon contributed to many textbooks and articles
dedicated to urolithiasis. He aimed to help all physicians,
including nephrologists and urologists certiﬁed or in
training, to improve their knowledge in the ﬁeld of uro-
lithiasis and understand the complex lithogenic mecha-
nisms so that they could:
 adapt their handling of urolithiasis, which is a public
health problem;
 reduce the recurrence risk, which can be cost-
effective for the healthcare system [71].
Two editions of collaborative books were published,
associating nephrologists with biologists and urologists.
They presented an exhaustive and updated survey on
urolithiasis, including the recent advances, as an expression
of Daudon’s willingness in the transmission of validated
knowledge [72,73].3. Conclusions
The importance of Daudon’s work in the ﬁeld of uro-
lithiasis is a trump card for the community of urologists
who were lucky to meet him. His contribution to a better
understanding of lithogenesis, his emphasis on systematic
physical analysis of stone fragments after urologictreatment may hopefully point to a reduction of the stone
recurrence rate, which remains at a high level although
technical progress.
The future must be imagined. Daudon is an unresting
worker and the urologists hope they will rely on his suc-
cessor, whose task will be hard.
Indeed, urolithiasis, the core of our job, found in
M. Daudon its cornerstone: his original work must resist to
the shock waves of the passage of time…References
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